EMA — authorised 20 May 2020
- Marketing authorisation holder: Bristol-Myers Squibb Pharma EEIG
- Status: approved
🇪🇺 Zeposia in European Union
EMA authorised Zeposia on 20 May 2020
Marketing authorisation
Zeposia in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in European Union
Frequently asked questions
Is Zeposia approved in European Union?
Yes. EMA authorised it on 20 May 2020.
Who is the marketing authorisation holder for Zeposia in European Union?
Bristol-Myers Squibb Pharma EEIG holds the EU marketing authorisation.